Sign in
4/A

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-057531

Principal Accounting Officer sold 307 shares at $8.87 ($2,723)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PISKEL KYLE Principal Accounting Officer 2022-11-16 Sale −307 $8.87 $2,723 47,358 D: show line 1 in the form
Open-market sales · 307 sh · avg $8.87 · $2,723
Loading xslF345X03/doc4a.xml…